| 12.0 |
72.3 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 4.1 |
16.4 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 3.9 |
31.4 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 3.6 |
10.9 |
GO:0015728 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 3.5 |
10.4 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 3.5 |
10.4 |
GO:0031662 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 3.0 |
8.9 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 2.8 |
8.4 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 2.8 |
8.4 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 2.7 |
11.0 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 2.7 |
11.0 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.6 |
7.8 |
GO:1904303 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 2.5 |
9.9 |
GO:0030822 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 2.4 |
7.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 2.4 |
52.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 2.2 |
8.9 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 2.2 |
4.4 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 2.1 |
6.3 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 2.1 |
6.2 |
GO:2000309 |
activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 2.0 |
6.0 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 2.0 |
5.9 |
GO:0036058 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 1.9 |
1.9 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 1.9 |
15.0 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.9 |
5.6 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.8 |
5.4 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 1.8 |
5.3 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 1.7 |
3.4 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 1.7 |
15.1 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.7 |
5.0 |
GO:0048627 |
myoblast development(GO:0048627) |
| 1.7 |
16.6 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.6 |
6.5 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 1.6 |
4.8 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 1.6 |
1.6 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.6 |
4.7 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 1.6 |
9.4 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 1.5 |
3.0 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 1.5 |
3.0 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 1.5 |
7.4 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 1.5 |
2.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.4 |
5.8 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 1.4 |
1.4 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 1.4 |
7.2 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 1.4 |
4.3 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 1.4 |
1.4 |
GO:0014013 |
regulation of gliogenesis(GO:0014013) |
| 1.4 |
4.2 |
GO:1900081 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.4 |
5.5 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 1.4 |
9.5 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 1.3 |
14.5 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.3 |
3.9 |
GO:1904172 |
regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 1.3 |
6.5 |
GO:0060356 |
leucine import(GO:0060356) |
| 1.3 |
11.4 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 1.3 |
1.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 1.2 |
13.7 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 1.2 |
2.5 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 1.2 |
9.8 |
GO:0042695 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.2 |
1.2 |
GO:1903438 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.2 |
4.9 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.2 |
3.6 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 1.2 |
9.5 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 |
4.8 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 1.2 |
8.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.2 |
1.2 |
GO:0007051 |
spindle organization(GO:0007051) |
| 1.2 |
7.0 |
GO:0009099 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.2 |
6.9 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 1.2 |
1.2 |
GO:1900195 |
positive regulation of oocyte maturation(GO:1900195) |
| 1.1 |
3.4 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 1.1 |
5.7 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.1 |
2.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.1 |
2.2 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 1.1 |
1.1 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 1.1 |
4.4 |
GO:1900535 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.1 |
3.3 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 1.1 |
28.5 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.1 |
3.3 |
GO:0002835 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.1 |
13.0 |
GO:0009629 |
response to gravity(GO:0009629) |
| 1.1 |
6.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.1 |
4.2 |
GO:0045575 |
basophil activation(GO:0045575) |
| 1.1 |
4.2 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.1 |
3.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.0 |
5.2 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 1.0 |
8.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 |
4.1 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 1.0 |
3.0 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.0 |
6.1 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.0 |
7.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.0 |
1.0 |
GO:0042391 |
regulation of membrane potential(GO:0042391) |
| 1.0 |
5.0 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 1.0 |
6.0 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
| 1.0 |
12.9 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.0 |
4.9 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 1.0 |
8.8 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.0 |
6.8 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 1.0 |
22.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 1.0 |
2.9 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 1.0 |
21.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 1.0 |
19.1 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) |
| 0.9 |
2.8 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 |
1.9 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.9 |
6.6 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.9 |
2.8 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.9 |
26.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.9 |
1.8 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.9 |
2.8 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.9 |
3.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.9 |
3.7 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.9 |
0.9 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.9 |
9.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.9 |
0.9 |
GO:0002543 |
activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.9 |
1.8 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.9 |
1.8 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.9 |
4.4 |
GO:0018126 |
protein hydroxylation(GO:0018126) peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 |
2.6 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.9 |
2.6 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.9 |
4.3 |
GO:1905040 |
vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.9 |
2.6 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.9 |
2.6 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.9 |
9.5 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.9 |
4.3 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.8 |
1.7 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.8 |
2.5 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.8 |
5.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.8 |
2.5 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.8 |
2.5 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.8 |
3.3 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.8 |
17.1 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.8 |
5.7 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.8 |
0.8 |
GO:0030522 |
intracellular receptor signaling pathway(GO:0030522) |
| 0.8 |
4.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.8 |
3.2 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.8 |
2.4 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 |
0.8 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.8 |
1.6 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.8 |
2.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.8 |
1.6 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.8 |
2.3 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.8 |
2.3 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.8 |
3.8 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.8 |
0.8 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.8 |
0.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.7 |
5.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.7 |
1.5 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.7 |
3.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 |
5.9 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.7 |
2.2 |
GO:0035290 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.7 |
0.7 |
GO:0010888 |
negative regulation of lipid storage(GO:0010888) |
| 0.7 |
0.7 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.7 |
0.7 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.7 |
3.7 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.7 |
3.6 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.7 |
2.9 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.7 |
1.4 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 0.7 |
2.2 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.7 |
2.2 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.7 |
3.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.7 |
2.2 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.7 |
0.7 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.7 |
3.6 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.7 |
2.1 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.7 |
2.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.7 |
6.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.7 |
1.4 |
GO:0002476 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.7 |
2.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 |
2.1 |
GO:2001035 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.7 |
2.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.7 |
2.1 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.7 |
3.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 |
3.5 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.7 |
3.5 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.7 |
0.7 |
GO:0060720 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.7 |
5.5 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.7 |
2.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.7 |
2.7 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.7 |
3.4 |
GO:0031337 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.7 |
4.8 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.7 |
2.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.7 |
3.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.7 |
4.1 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.7 |
2.0 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.7 |
1.3 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.7 |
2.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.7 |
4.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 |
82.8 |
GO:0070268 |
cornification(GO:0070268) |
| 0.7 |
4.7 |
GO:0070305 |
response to cGMP(GO:0070305) |
| 0.7 |
2.0 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.7 |
4.0 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.7 |
2.0 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.7 |
5.3 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.7 |
0.7 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.7 |
3.3 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.7 |
2.0 |
GO:0097254 |
renal tubular secretion(GO:0097254) |
| 0.6 |
3.9 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.6 |
1.9 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.6 |
0.6 |
GO:0035378 |
carbon dioxide transmembrane transport(GO:0035378) |
| 0.6 |
2.6 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.6 |
1.3 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.6 |
1.9 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.6 |
12.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.6 |
2.5 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.6 |
1.9 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 |
3.1 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.6 |
0.6 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.6 |
3.1 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 |
1.8 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.6 |
0.6 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.6 |
2.5 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.6 |
0.6 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.6 |
3.7 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.6 |
2.4 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.6 |
0.6 |
GO:1903923 |
protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.6 |
1.8 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.6 |
1.8 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.6 |
2.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.6 |
2.4 |
GO:0046104 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.6 |
3.6 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.6 |
6.6 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 |
0.6 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.6 |
2.4 |
GO:0034625 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 |
3.6 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.6 |
0.6 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.6 |
0.6 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.6 |
2.9 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.6 |
0.6 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.6 |
0.6 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.6 |
2.3 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.6 |
3.5 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.6 |
1.7 |
GO:1904640 |
response to methionine(GO:1904640) |
| 0.6 |
1.7 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.6 |
3.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.6 |
0.6 |
GO:0044848 |
biological phase(GO:0044848) |
| 0.6 |
1.7 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.6 |
2.9 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.6 |
1.7 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 |
3.4 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.6 |
6.3 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.6 |
2.3 |
GO:0071224 |
cellular response to peptidoglycan(GO:0071224) |
| 0.6 |
3.4 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.6 |
2.3 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.6 |
1.7 |
GO:1904387 |
cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.6 |
1.7 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.6 |
0.6 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.6 |
1.7 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.6 |
2.2 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.6 |
1.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.6 |
0.6 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.6 |
2.2 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.6 |
0.6 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.6 |
2.8 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.6 |
3.9 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.6 |
12.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.6 |
5.5 |
GO:0006469 |
negative regulation of protein kinase activity(GO:0006469) |
| 0.6 |
2.8 |
GO:0007418 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.5 |
0.5 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.5 |
0.5 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.5 |
4.9 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
1.6 |
GO:0035565 |
regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.5 |
1.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.5 |
3.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.5 |
1.1 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.5 |
0.5 |
GO:0015966 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 |
5.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.5 |
1.6 |
GO:1901994 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 |
2.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.5 |
0.5 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.5 |
1.6 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
3.2 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 |
1.6 |
GO:1903964 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 |
5.8 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 |
2.1 |
GO:0060694 |
regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.5 |
1.6 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.5 |
2.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.5 |
0.5 |
GO:0031335 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.5 |
1.0 |
GO:0035854 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.5 |
0.5 |
GO:0016045 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.5 |
1.0 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.5 |
4.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.5 |
4.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 |
2.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.5 |
2.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 |
1.0 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 |
2.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 |
1.5 |
GO:1903925 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 |
4.1 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.5 |
1.0 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.5 |
5.6 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.5 |
1.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
1.5 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.5 |
1.0 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.5 |
1.5 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.5 |
4.0 |
GO:0006366 |
transcription from RNA polymerase II promoter(GO:0006366) |
| 0.5 |
4.9 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.5 |
1.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.5 |
7.3 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.5 |
3.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.5 |
1.5 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.5 |
4.4 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.5 |
0.5 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 |
1.9 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.5 |
2.4 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.5 |
5.8 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 |
1.0 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.5 |
1.0 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.5 |
4.3 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.5 |
2.9 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.5 |
1.0 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.5 |
2.4 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.5 |
7.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.5 |
8.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.5 |
3.8 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.5 |
6.1 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 |
0.9 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.5 |
2.3 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 |
0.5 |
GO:0003231 |
cardiac ventricle development(GO:0003231) |
| 0.5 |
9.8 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.5 |
2.3 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.5 |
0.9 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.5 |
2.3 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.5 |
0.5 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.5 |
1.4 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.5 |
0.5 |
GO:0043103 |
hypoxanthine salvage(GO:0043103) |
| 0.5 |
5.5 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.5 |
0.9 |
GO:0030278 |
regulation of ossification(GO:0030278) |
| 0.5 |
1.4 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 |
1.4 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.5 |
3.6 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.5 |
0.9 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.5 |
2.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.4 |
0.9 |
GO:0048936 |
peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.4 |
0.4 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.4 |
5.8 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.4 |
2.2 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 |
2.7 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.4 |
1.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.4 |
4.4 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.4 |
1.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.4 |
1.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 |
5.7 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 |
0.9 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.4 |
1.3 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.4 |
1.3 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.4 |
0.9 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 |
0.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 |
2.6 |
GO:1901906 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.4 |
1.7 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 |
1.3 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.4 |
0.9 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.4 |
3.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.4 |
2.1 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 |
6.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.4 |
4.2 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.4 |
0.4 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.4 |
3.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.4 |
1.3 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 |
3.3 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
1.3 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.4 |
1.3 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.4 |
1.7 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.4 |
0.8 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.4 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.4 |
1.6 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 |
6.6 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 |
10.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 |
2.1 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.4 |
1.2 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 |
6.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.4 |
2.0 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.4 |
0.8 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
| 0.4 |
5.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.4 |
2.8 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.4 |
6.0 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.4 |
7.2 |
GO:1904261 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 |
0.8 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.4 |
1.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.4 |
5.6 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.4 |
9.5 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.4 |
0.8 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 |
2.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 |
6.3 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.4 |
2.0 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.4 |
5.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.4 |
2.0 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.4 |
2.0 |
GO:0070980 |
biphenyl catabolic process(GO:0070980) |
| 0.4 |
0.4 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.4 |
2.7 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.4 |
1.6 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.4 |
2.0 |
GO:0055011 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 |
3.1 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.4 |
1.6 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.4 |
1.2 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.4 |
2.3 |
GO:0002248 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 0.4 |
1.2 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 |
0.4 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.4 |
1.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 |
2.7 |
GO:0043622 |
cortical microtubule organization(GO:0043622) |
| 0.4 |
1.1 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 |
3.1 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.4 |
4.2 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.4 |
0.8 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
0.8 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.4 |
3.4 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.4 |
3.0 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 |
1.9 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 |
4.1 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.4 |
1.1 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.4 |
1.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.4 |
1.9 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.4 |
1.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.4 |
0.4 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.4 |
2.2 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.4 |
0.7 |
GO:0034971 |
histone H3-R17 methylation(GO:0034971) |
| 0.4 |
0.7 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
2.6 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.4 |
1.9 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.4 |
1.5 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.4 |
1.5 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.4 |
1.1 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.4 |
0.4 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.4 |
7.0 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.4 |
3.7 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.4 |
1.5 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.4 |
2.9 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.4 |
0.7 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
4.0 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.4 |
2.2 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.4 |
0.4 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.4 |
0.4 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.4 |
0.7 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.4 |
2.5 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.4 |
1.4 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.4 |
2.9 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 |
1.1 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.4 |
0.4 |
GO:1903094 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.4 |
1.1 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.4 |
2.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.4 |
1.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
1.8 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.4 |
1.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) |
| 0.4 |
0.4 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.4 |
12.5 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.4 |
8.9 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.4 |
0.4 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.4 |
1.4 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.4 |
0.4 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.4 |
0.4 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.4 |
0.7 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.4 |
0.4 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.4 |
1.4 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.4 |
1.4 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
2.5 |
GO:0021840 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.4 |
1.8 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.4 |
2.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 |
0.3 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 0.3 |
2.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.3 |
0.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.3 |
0.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) purine nucleobase salvage(GO:0043096) |
| 0.3 |
2.4 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 |
1.0 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.3 |
4.5 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.3 |
0.3 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 |
2.4 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 |
4.5 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.3 |
15.8 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.3 |
4.5 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.3 |
2.4 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
1.0 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.3 |
0.7 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.3 |
3.0 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 |
3.7 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.3 |
1.7 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.3 |
1.7 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.3 |
16.4 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.3 |
0.7 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.3 |
3.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
1.3 |
GO:0021557 |
optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) |
| 0.3 |
0.3 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.3 |
4.7 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.3 |
0.3 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) |
| 0.3 |
1.3 |
GO:0036510 |
trimming of terminal mannose on C branch(GO:0036510) |
| 0.3 |
1.0 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.3 |
0.7 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.3 |
5.6 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.3 |
2.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 |
2.0 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.3 |
1.6 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.3 |
0.3 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) |
| 0.3 |
1.6 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.3 |
1.6 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
0.7 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 |
5.2 |
GO:0090520 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
0.3 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.3 |
3.6 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.3 |
1.0 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 |
0.7 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.3 |
0.3 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.3 |
1.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.3 |
0.6 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.3 |
3.5 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 |
1.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 |
1.0 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
1.0 |
GO:0018012 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.3 |
0.3 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.3 |
1.6 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.3 |
0.3 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.3 |
1.6 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 |
8.2 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.3 |
1.6 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 |
6.3 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 |
1.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
0.6 |
GO:0045196 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 |
1.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
0.9 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
0.6 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.3 |
0.3 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 |
1.6 |
GO:0099639 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.3 |
1.2 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.3 |
0.6 |
GO:0072393 |
microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.3 |
0.6 |
GO:0014724 |
regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.3 |
2.2 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.3 |
3.7 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 |
0.9 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
0.6 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.3 |
0.3 |
GO:1902713 |
regulation of interferon-gamma secretion(GO:1902713) positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.3 |
0.3 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.3 |
0.9 |
GO:0071048 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.3 |
0.9 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.3 |
2.1 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.3 |
2.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
2.4 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
1.2 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.3 |
0.9 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.3 |
3.3 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.3 |
1.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.3 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.3 |
0.6 |
GO:0032759 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.3 |
1.5 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.3 |
3.3 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
0.6 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.3 |
2.7 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.3 |
0.6 |
GO:1903308 |
regulation of chromatin modification(GO:1903308) |
| 0.3 |
0.3 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.3 |
1.8 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.3 |
0.3 |
GO:1903961 |
positive regulation of anion transmembrane transport(GO:1903961) |
| 0.3 |
1.8 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
0.3 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.3 |
1.8 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 |
0.3 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) |
| 0.3 |
0.9 |
GO:0034963 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.3 |
0.9 |
GO:0050777 |
negative regulation of immune response(GO:0050777) |
| 0.3 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.3 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
0.9 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.3 |
0.9 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
6.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
0.9 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.3 |
2.3 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.3 |
1.7 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.3 |
3.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.3 |
0.3 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.3 |
1.7 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.3 |
3.1 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
1.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
2.0 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 |
0.3 |
GO:0097191 |
extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.3 |
1.1 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.3 |
1.1 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 |
1.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
1.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.3 |
0.3 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.3 |
1.4 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.3 |
0.3 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
2.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 |
0.3 |
GO:1902932 |
positive regulation of alcohol biosynthetic process(GO:1902932) |
| 0.3 |
0.8 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 |
3.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.3 |
2.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.6 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.3 |
3.4 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.3 |
0.6 |
GO:0097325 |
melanocyte proliferation(GO:0097325) |
| 0.3 |
1.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 |
0.3 |
GO:0005989 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.3 |
1.1 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.3 |
4.5 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.3 |
3.6 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 |
0.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.3 |
5.8 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.3 |
0.8 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.3 |
10.0 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
0.8 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
3.0 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 |
1.4 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.3 |
1.9 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.3 |
0.8 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.3 |
0.5 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 |
0.8 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.3 |
0.5 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.3 |
0.3 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.3 |
0.8 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.3 |
0.3 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.3 |
1.6 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.3 |
0.8 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.1 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 |
0.8 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.3 |
0.5 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.3 |
0.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 |
1.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 |
1.4 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.3 |
1.9 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 |
0.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.3 |
0.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.3 |
1.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 |
0.5 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.3 |
1.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
2.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
0.8 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 |
2.1 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
2.9 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.3 |
0.8 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 |
8.5 |
GO:0097340 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.3 |
0.8 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.3 |
2.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.3 |
3.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
1.3 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 |
0.8 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.3 |
3.4 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 |
0.5 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.3 |
1.6 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 |
0.5 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.3 |
1.8 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 |
13.0 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.3 |
12.0 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.3 |
1.6 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.3 |
1.3 |
GO:2000852 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.3 |
1.3 |
GO:0003069 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
4.9 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 |
0.5 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.3 |
1.0 |
GO:0019413 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.3 |
1.0 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 |
0.3 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.3 |
14.0 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.3 |
2.3 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.3 |
0.3 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.3 |
1.5 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
1.3 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.3 |
3.3 |
GO:0006705 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.3 |
0.3 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 |
0.8 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.3 |
0.3 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.2 |
1.0 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.2 |
1.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 |
3.0 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
2.0 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 |
0.5 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.2 |
1.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
0.5 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.2 |
0.5 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.2 |
0.2 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 |
0.7 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 |
0.7 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.2 |
1.9 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.2 |
0.7 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
0.5 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.2 |
0.2 |
GO:0002860 |
positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.2 |
1.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
1.0 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.2 |
0.7 |
GO:0007623 |
circadian rhythm(GO:0007623) |
| 0.2 |
1.4 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
1.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
1.4 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
8.8 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.2 |
5.7 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
0.7 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 |
0.5 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
0.2 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.2 |
0.2 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
23.4 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.2 |
1.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.2 |
1.2 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 |
0.7 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 |
1.6 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.2 |
1.4 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.2 |
1.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
2.3 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
0.7 |
GO:0051344 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 |
0.7 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.2 |
0.2 |
GO:0044818 |
mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
| 0.2 |
0.5 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.2 |
0.2 |
GO:0071774 |
response to fibroblast growth factor(GO:0071774) |
| 0.2 |
0.9 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 |
0.9 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
0.2 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 0.2 |
0.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.5 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.2 |
1.2 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 |
0.5 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.2 |
2.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
2.7 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 |
1.4 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 |
1.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.2 |
1.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
0.9 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.5 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.2 |
0.5 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
2.5 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 |
0.5 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
5.2 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
1.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
2.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.5 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.2 |
0.7 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.2 |
2.3 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
0.7 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
2.0 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.2 |
5.4 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.2 |
0.7 |
GO:0021644 |
vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.2 |
1.6 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 |
1.6 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.2 |
0.2 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.2 |
1.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
0.9 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.2 |
0.7 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.2 |
0.9 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
0.7 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.2 |
12.2 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
2.2 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
2.2 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 |
0.7 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.2 |
0.9 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
6.2 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 |
1.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
0.2 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.2 |
0.4 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.2 |
0.7 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 |
0.7 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 |
0.9 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.2 |
0.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.2 |
0.2 |
GO:0036446 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.2 |
0.9 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.2 |
3.4 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.2 |
5.8 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.2 |
0.6 |
GO:1990144 |
intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.2 |
0.4 |
GO:1904751 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
0.9 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.2 |
0.9 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.4 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.2 |
2.4 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
2.6 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.2 |
1.1 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.2 |
0.6 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.2 |
0.4 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.2 |
0.2 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.2 |
GO:0002652 |
regulation of tolerance induction dependent upon immune response(GO:0002652) positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.2 |
0.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
1.3 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
0.8 |
GO:0051583 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 |
1.1 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.2 |
0.8 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 |
0.4 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 |
2.1 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
0.2 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.2 |
0.4 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.2 |
0.6 |
GO:1903936 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.2 |
0.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
0.6 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.2 |
0.6 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.2 |
0.4 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 |
2.7 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.2 |
1.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 |
1.2 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.2 |
1.2 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
0.8 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.2 |
1.4 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.2 |
0.8 |
GO:0034776 |
response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.2 |
0.6 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.2 |
0.8 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 |
1.0 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 |
1.0 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.2 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.2 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
2.0 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.2 |
0.6 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.2 |
0.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.2 |
1.4 |
GO:0031100 |
organ regeneration(GO:0031100) |
| 0.2 |
0.2 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.2 |
2.8 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 |
4.8 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.2 |
1.0 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.2 |
0.6 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 |
0.8 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.2 |
0.2 |
GO:0071362 |
cellular response to ether(GO:0071362) |
| 0.2 |
1.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.2 |
2.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
1.6 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 |
2.8 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 |
2.0 |
GO:0007567 |
parturition(GO:0007567) |
| 0.2 |
0.2 |
GO:2000106 |
lymphocyte apoptotic process(GO:0070227) leukocyte apoptotic process(GO:0071887) regulation of leukocyte apoptotic process(GO:2000106) |
| 0.2 |
2.5 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.2 |
1.4 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.2 |
0.4 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 |
0.2 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.2 |
1.5 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 |
0.2 |
GO:0055081 |
anion homeostasis(GO:0055081) |
| 0.2 |
0.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.4 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
0.4 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 |
5.5 |
GO:1902850 |
microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.2 |
4.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.2 |
1.3 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 |
0.6 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 |
0.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 |
0.8 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.2 |
1.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
0.9 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
0.9 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.2 |
0.2 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.2 |
0.2 |
GO:1903034 |
regulation of response to wounding(GO:1903034) |
| 0.2 |
0.2 |
GO:1901976 |
regulation of cell cycle checkpoint(GO:1901976) |
| 0.2 |
0.6 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
3.0 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.2 |
0.2 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.2 |
0.2 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.2 |
0.2 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 |
0.7 |
GO:0046833 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 |
1.1 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
0.5 |
GO:0050720 |
interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.2 |
1.8 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.2 |
1.8 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
3.1 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 |
1.3 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.2 |
0.9 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.2 |
0.7 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.2 |
0.5 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.2 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.2 |
3.4 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.2 |
2.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.2 |
0.9 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.2 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 |
2.1 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.2 |
0.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
1.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 |
0.2 |
GO:1903401 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.2 |
3.6 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.2 |
0.5 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
0.2 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.2 |
0.2 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.2 |
1.1 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.2 |
1.9 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
0.7 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 |
1.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
0.5 |
GO:0090287 |
regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.2 |
0.7 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.2 |
0.5 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 |
1.4 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 |
2.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
0.4 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
0.9 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.2 |
1.9 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
0.5 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.2 |
2.1 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.2 |
0.3 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.2 |
0.7 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 |
0.3 |
GO:1903278 |
regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) positive regulation of potassium ion import(GO:1903288) |
| 0.2 |
1.0 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.2 |
2.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
0.2 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 |
0.9 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
3.6 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
0.3 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
0.7 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 |
1.0 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.2 |
0.9 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
0.5 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 |
0.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
1.4 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.2 |
0.5 |
GO:0021816 |
lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.2 |
1.5 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.2 |
0.7 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.2 |
3.6 |
GO:1903514 |
calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
| 0.2 |
0.5 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.2 |
0.7 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 |
0.5 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.2 |
0.7 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 |
0.7 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.2 |
0.3 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.2 |
0.5 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
2.3 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.2 |
0.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
1.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.8 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 |
2.0 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.2 |
1.7 |
GO:0044036 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.2 |
1.3 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 |
0.5 |
GO:1903778 |
autophagic cell death(GO:0048102) protein localization to vacuolar membrane(GO:1903778) |
| 0.2 |
1.2 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
0.5 |
GO:0043368 |
positive T cell selection(GO:0043368) negative T cell selection(GO:0043383) |
| 0.2 |
1.0 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.2 |
0.8 |
GO:0009732 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.2 |
1.8 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.2 |
0.5 |
GO:0031456 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 |
0.3 |
GO:1900453 |
negative regulation of long term synaptic depression(GO:1900453) |
| 0.2 |
1.1 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.2 |
0.3 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
0.6 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.2 |
0.6 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.2 |
0.5 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 |
6.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 |
0.2 |
GO:0060026 |
convergent extension(GO:0060026) convergent extension involved in gastrulation(GO:0060027) |
| 0.2 |
1.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.2 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.2 |
0.3 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.2 |
0.3 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.2 |
0.8 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.6 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 |
0.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
3.0 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
1.9 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.2 |
1.1 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
0.3 |
GO:0051055 |
negative regulation of lipid biosynthetic process(GO:0051055) |
| 0.2 |
0.5 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.2 |
0.2 |
GO:0010628 |
positive regulation of gene expression(GO:0010628) |
| 0.2 |
1.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 |
2.1 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.2 |
1.1 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.2 |
0.5 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.2 |
1.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
2.2 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.2 |
0.3 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.2 |
2.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 |
0.6 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.2 |
1.7 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.2 |
1.2 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.2 |
0.3 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 0.2 |
0.3 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.2 |
1.2 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
0.8 |
GO:0015864 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.2 |
0.9 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
0.3 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 |
7.1 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.2 |
6.5 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.2 |
1.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
2.8 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 |
0.3 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.2 |
0.2 |
GO:0014891 |
skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
| 0.2 |
2.4 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 |
0.6 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 |
0.6 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 |
0.2 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
8.3 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 |
0.2 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.2 |
0.3 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.1 |
0.4 |
GO:1901053 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
1.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
1.3 |
GO:0030803 |
negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
| 0.1 |
0.6 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.1 |
1.0 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
1.0 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
1.3 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
3.8 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.1 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 |
0.3 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 |
0.4 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
4.9 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.1 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) |
| 0.1 |
0.1 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.9 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.1 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.1 |
0.6 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 |
0.3 |
GO:1990668 |
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.1 |
2.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
5.8 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.1 |
0.1 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 |
1.6 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
2.2 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.1 |
GO:0045684 |
positive regulation of epidermis development(GO:0045684) |
| 0.1 |
0.6 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
1.0 |
GO:0032740 |
positive regulation of interleukin-17 production(GO:0032740) |
| 0.1 |
1.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.9 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
0.6 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.7 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
3.1 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.4 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 |
0.3 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
1.7 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.3 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
0.4 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 |
0.3 |
GO:1990138 |
neuron projection extension(GO:1990138) |
| 0.1 |
2.3 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
2.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
2.1 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.7 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
1.0 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.1 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.3 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.1 |
2.6 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.1 |
0.1 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 |
0.3 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
1.2 |
GO:1990035 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
1.0 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
1.4 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
1.2 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.1 |
0.3 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.3 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 |
0.7 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.4 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
5.8 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.1 |
1.3 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.1 |
0.8 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.5 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
8.4 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.1 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
2.9 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.1 |
0.1 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.1 |
0.4 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
1.6 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
1.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.4 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
1.2 |
GO:0002717 |
positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.1 |
0.5 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
1.6 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.1 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.1 |
0.3 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.3 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
9.1 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
1.2 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.8 |
GO:0043306 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.5 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 |
0.1 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.1 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.3 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.1 |
GO:0010916 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.1 |
1.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.4 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.1 |
0.9 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.8 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.3 |
GO:0030647 |
aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.1 |
16.0 |
GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 |
0.5 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.5 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.6 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.4 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
0.4 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.1 |
0.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.6 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.4 |
GO:0086043 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.1 |
0.5 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
5.6 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
3.0 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.1 |
0.2 |
GO:0021548 |
pons development(GO:0021548) |
| 0.1 |
0.2 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
2.4 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 |
3.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.1 |
0.2 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 |
0.1 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.1 |
1.8 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
1.3 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 |
10.1 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.1 |
1.3 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.1 |
0.6 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
1.4 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
0.8 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.2 |
GO:1904100 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 |
0.6 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.1 |
0.6 |
GO:0045187 |
regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 |
0.4 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.2 |
GO:2000109 |
regulation of macrophage apoptotic process(GO:2000109) |
| 0.1 |
0.2 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.1 |
0.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
0.7 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
5.0 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
3.7 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.1 |
1.4 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.1 |
0.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.2 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 0.1 |
0.5 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
1.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
8.0 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.7 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
1.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
2.0 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 |
2.3 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.1 |
GO:0008585 |
female gonad development(GO:0008585) female sex differentiation(GO:0046660) |
| 0.1 |
0.6 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.2 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.8 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.3 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.6 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 |
0.6 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.2 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.1 |
GO:1903898 |
regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
0.4 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.1 |
0.3 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 |
1.0 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.1 |
0.3 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.1 |
0.3 |
GO:0010949 |
negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.1 |
0.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.8 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.1 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 |
0.3 |
GO:0045732 |
positive regulation of protein catabolic process(GO:0045732) |
| 0.1 |
1.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.2 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.1 |
1.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.3 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 |
0.2 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 |
0.4 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
0.4 |
GO:0006216 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.5 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.3 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.1 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.1 |
3.5 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.3 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.1 |
0.5 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
0.2 |
GO:1900003 |
regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
| 0.1 |
0.5 |
GO:0044254 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
1.0 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
1.0 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.4 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.3 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 |
4.9 |
GO:0000819 |
sister chromatid segregation(GO:0000819) |
| 0.1 |
0.3 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 |
0.7 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.4 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.1 |
0.2 |
GO:0008207 |
C21-steroid hormone metabolic process(GO:0008207) |
| 0.1 |
0.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
0.4 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.1 |
0.1 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.2 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.1 |
0.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
0.3 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.1 |
0.3 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.1 |
0.2 |
GO:0051962 |
positive regulation of nervous system development(GO:0051962) |
| 0.1 |
0.4 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.3 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
0.2 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.2 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.1 |
0.4 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 |
1.1 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.4 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
| 0.1 |
0.3 |
GO:1900225 |
regulation of NLRP3 inflammasome complex assembly(GO:1900225) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
1.0 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.4 |
GO:0051983 |
regulation of chromosome segregation(GO:0051983) |
| 0.1 |
0.5 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.3 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
0.4 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.5 |
GO:0010907 |
positive regulation of glucose metabolic process(GO:0010907) |
| 0.1 |
0.3 |
GO:1903555 |
regulation of tumor necrosis factor superfamily cytokine production(GO:1903555) |
| 0.1 |
0.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.4 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.8 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.2 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
1.3 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.2 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.1 |
4.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
9.5 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
0.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.4 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.6 |
GO:0032094 |
response to food(GO:0032094) |
| 0.1 |
0.6 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.1 |
1.0 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.5 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.2 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 |
0.6 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
0.4 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.3 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
0.5 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.1 |
0.3 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.4 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.1 |
0.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.3 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
1.9 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 |
0.1 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.1 |
1.1 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 |
0.6 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 |
0.1 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.2 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 |
0.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.1 |
GO:0032945 |
negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
| 0.1 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
0.3 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.5 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 |
0.7 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
1.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.2 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.3 |
GO:0030282 |
bone mineralization(GO:0030282) |
| 0.1 |
0.9 |
GO:0003300 |
cardiac muscle hypertrophy(GO:0003300) |
| 0.1 |
0.2 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
0.4 |
GO:0098870 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.1 |
0.2 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.1 |
0.2 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.4 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 |
1.0 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.5 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.1 |
0.3 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.1 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
1.0 |
GO:1900274 |
regulation of phospholipase C activity(GO:1900274) |
| 0.1 |
0.1 |
GO:0006475 |
internal protein amino acid acetylation(GO:0006475) internal peptidyl-lysine acetylation(GO:0018393) |
| 0.1 |
0.2 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
0.5 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 |
0.2 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.1 |
0.3 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.2 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.1 |
0.4 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 |
0.2 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
0.2 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.1 |
0.2 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.1 |
1.0 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.6 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.1 |
0.2 |
GO:0048867 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.1 |
0.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.5 |
GO:0038094 |
Fc-gamma receptor signaling pathway(GO:0038094) |
| 0.1 |
0.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.2 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.1 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.1 |
1.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.3 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.6 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.1 |
GO:0002418 |
immune response to tumor cell(GO:0002418) |
| 0.1 |
2.4 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.2 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.1 |
0.2 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.2 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.1 |
0.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.2 |
GO:0003188 |
heart valve formation(GO:0003188) atrioventricular valve formation(GO:0003190) |
| 0.1 |
0.1 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.1 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.1 |
0.8 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
1.6 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
1.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
3.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.2 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.1 |
1.1 |
GO:0032438 |
melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.1 |
0.5 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.2 |
GO:0043543 |
protein acylation(GO:0043543) |
| 0.1 |
0.5 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 |
1.1 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
0.4 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.1 |
0.3 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.9 |
GO:0097192 |
signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.1 |
1.9 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
1.8 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.1 |
GO:1901382 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 |
0.4 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.1 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.5 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) |
| 0.1 |
0.2 |
GO:1901032 |
negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.1 |
0.2 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 |
0.2 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.1 |
1.1 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.4 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.3 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
1.7 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.3 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.1 |
0.3 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.1 |
0.4 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.3 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.1 |
0.1 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
1.5 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.1 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.1 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.3 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 |
3.9 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
1.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.3 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.1 |
GO:0072528 |
pyrimidine-containing compound biosynthetic process(GO:0072528) |
| 0.1 |
0.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
0.4 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.5 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.2 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.1 |
GO:0043588 |
skin development(GO:0043588) |
| 0.1 |
0.1 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.1 |
1.1 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.1 |
0.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.2 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.1 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.1 |
0.4 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
0.6 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.9 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
0.3 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.7 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 |
0.9 |
GO:0030817 |
regulation of cAMP biosynthetic process(GO:0030817) |
| 0.1 |
0.3 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.1 |
GO:1902623 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
2.3 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.6 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
0.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
3.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.1 |
0.3 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.1 |
GO:0019474 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 |
0.1 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
0.1 |
GO:1901490 |
regulation of lymphangiogenesis(GO:1901490) |
| 0.1 |
0.1 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 |
0.4 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.1 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
3.4 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.1 |
GO:0072364 |
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.1 |
0.2 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
6.0 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 |
0.6 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.2 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
0.4 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.1 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.1 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.1 |
2.0 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
7.3 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
0.2 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
0.5 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.1 |
0.1 |
GO:0071383 |
cellular response to steroid hormone stimulus(GO:0071383) |
| 0.1 |
1.6 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.1 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.1 |
GO:1904994 |
regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
| 0.1 |
0.1 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.1 |
0.1 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 |
0.4 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.2 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.6 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
0.3 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.2 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.1 |
0.1 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.1 |
1.0 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.1 |
GO:0006598 |
polyamine catabolic process(GO:0006598) spermine metabolic process(GO:0008215) |
| 0.1 |
0.5 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.2 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.1 |
GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.1 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.1 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
1.8 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.1 |
0.3 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.1 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
0.4 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.1 |
0.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.1 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 |
0.2 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.3 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.3 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.3 |
GO:0030210 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.3 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.1 |
0.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.8 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 |
0.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.1 |
0.9 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.2 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
1.5 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 |
0.1 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
1.6 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.7 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) |
| 0.1 |
0.7 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
0.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
2.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.4 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
0.2 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
2.5 |
GO:2000117 |
negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.1 |
0.2 |
GO:0034694 |
response to prostaglandin(GO:0034694) |
| 0.1 |
3.5 |
GO:0044344 |
cellular response to fibroblast growth factor stimulus(GO:0044344) |
| 0.1 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.1 |
GO:1990918 |
double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 |
0.9 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.0 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.0 |
0.1 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.0 |
0.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.1 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.0 |
0.9 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.3 |
GO:0046794 |
transport of virus(GO:0046794) |
| 0.0 |
0.1 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.0 |
0.1 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.0 |
0.2 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.3 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 |
0.4 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.4 |
GO:0050951 |
detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) |
| 0.0 |
0.4 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.1 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.3 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.0 |
0.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.0 |
0.5 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.3 |
GO:0046512 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 |
0.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.0 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.4 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.0 |
0.2 |
GO:0097061 |
dendritic spine organization(GO:0097061) |
| 0.0 |
0.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.6 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.2 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 |
0.2 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) |
| 0.0 |
8.8 |
GO:0007015 |
actin filament organization(GO:0007015) |
| 0.0 |
0.1 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.1 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.5 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.2 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 |
0.0 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.0 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 |
0.2 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.1 |
GO:0061582 |
intestinal epithelial cell migration(GO:0061582) |
| 0.0 |
0.6 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 |
0.0 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.0 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.2 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.2 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.0 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.0 |
0.0 |
GO:0036515 |
dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.0 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.2 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.1 |
GO:0051445 |
regulation of meiotic cell cycle(GO:0051445) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0051873 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.0 |
0.0 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
| 0.0 |
0.2 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 |
1.0 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 |
0.0 |
GO:0002664 |
regulation of T cell tolerance induction(GO:0002664) |
| 0.0 |
0.1 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.0 |
0.3 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
0.1 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.0 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.2 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.2 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
1.4 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
| 0.0 |
0.1 |
GO:0006925 |
inflammatory cell apoptotic process(GO:0006925) |
| 0.0 |
0.3 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.9 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.2 |
GO:0042992 |
negative regulation of transcription factor import into nucleus(GO:0042992) |
| 0.0 |
0.4 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.3 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.1 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.1 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 |
0.1 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) |
| 0.0 |
0.1 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 |
1.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.1 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.0 |
0.1 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.1 |
GO:0007163 |
establishment or maintenance of cell polarity(GO:0007163) |
| 0.0 |
0.2 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 |
0.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.3 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.1 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.1 |
GO:0051303 |
establishment of chromosome localization(GO:0051303) |
| 0.0 |
0.2 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.3 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.0 |
0.0 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0001897 |
cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 |
0.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.0 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.0 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.0 |
2.1 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
0.2 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.1 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.2 |
GO:0034391 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.4 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.2 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.0 |
0.2 |
GO:0006853 |
carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) |
| 0.0 |
0.1 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.1 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.0 |
0.2 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.7 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.0 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.1 |
GO:0042596 |
behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
| 0.0 |
0.2 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.2 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.0 |
0.1 |
GO:1902959 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.0 |
0.1 |
GO:1990774 |
tumor necrosis factor secretion(GO:1990774) |
| 0.0 |
0.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
0.4 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.3 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.0 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.1 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.3 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.1 |
GO:0002228 |
natural killer cell mediated immunity(GO:0002228) |
| 0.0 |
0.2 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.1 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.0 |
0.3 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.1 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.2 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.0 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.3 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.1 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.1 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.5 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.2 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.0 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 |
0.1 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0050685 |
positive regulation of mRNA processing(GO:0050685) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.0 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.0 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.0 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.0 |
0.2 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.0 |
0.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.2 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.0 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.1 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 |
0.2 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.1 |
GO:0033483 |
gas homeostasis(GO:0033483) |
| 0.0 |
0.0 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.0 |
0.1 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.0 |
0.0 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.0 |
0.1 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.0 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.0 |
0.0 |
GO:0009750 |
response to fructose(GO:0009750) |
| 0.0 |
0.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.1 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.0 |
0.1 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.1 |
GO:0030431 |
sleep(GO:0030431) |
| 0.0 |
0.0 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 0.0 |
0.2 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.0 |
0.1 |
GO:1901475 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.6 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.0 |
GO:0048144 |
fibroblast proliferation(GO:0048144) |
| 0.0 |
0.1 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 |
0.1 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.1 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.0 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.0 |
GO:0097491 |
sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.0 |
0.1 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.4 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.4 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.0 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.0 |
0.0 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.0 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 |
0.0 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.0 |
0.5 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.0 |
0.0 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 |
0.0 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.0 |
0.0 |
GO:1902563 |
regulation of neutrophil activation(GO:1902563) |
| 0.0 |
0.0 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
